Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

Pfizer and Blackstone Fund Berobenatide GLP-1 Obesity Trials

Pfizer secured up to $1.5 billion from Blackstone Life Sciences to fund berobenatide trials in obesity and related metabolic diseases.

By Dr. A. Nikhil Krishnan, MBBS · 2 hrs ago · 5 min read

Endocrinology·ScienceDaily

Animal and Plant Protein Linked to Different Testosterone Levels in Men

In more than 2,500 Finnish men, animal protein intake was linked to lower testosterone, while plant protein was…

4 hrs ago

Endocrinology·Nature

Menopausal Hormone Therapy Reshapes the Microbiome and Symptom Response

A 6-month study links menopausal hormone therapy to microbiome remodeling and shows baseline gut and vaginal communities shape…

4 hrs ago

Endocrinology·Diabetes Care

Sleep Optimization Trial Targets Glycemic Control in Type 1 Diabetes

A randomized parallel trial in adults with type 1 diabetes tests whether sleep optimization can help improve glycemic…

10 hrs ago

Endocrinology·Diabetes Care

Teplizumab Preserves Beta-Cell Function in Type 1 Diabetes

Integrated trial data show teplizumab preserved C-peptide and lowered insulin use in stage 3 type 1 diabetes, with…

10 hrs ago

Endocrinology·Diabetes Care

Intermittent Fasting and Fatty Liver: Sex and Ketogenesis Effects

A Diabetes Care abstract examines whether intermittent fasting alters diet-induced fatty liver disease through sex-specific and ketogenesis-dependent pathways.

10 hrs ago

Endocrinology·PLOS Med

Dietary Inflammatory Index Linked to Cardiovascular Risk in Type 2 Diabetes

A UK Biobank study found pro-inflammatory diets were tied to higher cardiovascular events and mortality in type 2…

15 hrs ago

Endocrinology·Diabetes Care

Age at Type 1 Diabetes Onset Linked to Survival, Cardiac and Kidney Outcomes

Nationwide cohort study examines how age at type 1 diabetes onset relates to survival, cardiovascular disease, and kidney…

16 hrs ago

Endocrinology·Diabetes Care

Serum Metabolites May Predict Teplizumab Response in Type 1 Diabetes

A Diabetes Care abstract examines whether baseline serum metabolites can help identify who responds to teplizumab in type…

16 hrs ago

Endocrinology·BMJ Open

HABIT-GEMs protocol tests henagliflozin vs metformin in older adults with diabetes

BMJ Open protocol examines henagliflozin versus metformin in older adults with new type 2 diabetes, focusing on body…

17 hrs ago

Endocrinology

Trials, guidelines and clinical evidence across Endocrinology.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.